Abstract
Transdermal drug delivery offers several advantages over traditional drug delivery systems such as oral delivery and injection, especially in regard to protein delivery.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
A.J. Coleman and J.E. Saunders. A review of the physical properties and biological effects of the high amplitude acoustic field used in extracorporeal lithotripsy. Ultrasonics, 31:75–89, 1993.
C.J. Diederich and K. Hynnen. Ultrasound technology for hyperthemia. Ultrasound Med. Biol., 25:871–887, 1999.
A.V. Alexandrov. Ultrasound-enhanced thrombolysis for stroke: clinical significance. Eur. J. Ultrasound, 16:131–140, 2002.
J.C. Goes and A. Landecker. Ultrasound-induced lipoplasty (UAL) in breast surgery. Aesthetic Plast. Surg., 26:1–9, 2002.
C.A. Speed. Therapeutic ultrasound in soft tissue lesions. Rheumatology, 40:1331–1336, 2001.
M. Hadjiargyrou, K. McLeod, J.P. Ryaby, and C. Rubin.Enhancement of fracture healing by low intensity Ultrasound. Clin. Orthop., 355(Suppl):S216–S229, 1998.
A. Tezel, A. Sens, J. Tuscherer, and S. Mitragotri. Frequency dependece of sonophoresis. Pharm. Res., 18:1694–1700, 2001.
S. Mitragotri, D. Blankschtein, and R. Langer, Ultrasound-mediated transdermal protein delivery. Science, 269:850–853, 1995.
H. Tang, D. Blankschtein, and R. Langer. An investigation of the role of cavitation in low-ferquency ultrasound-mediated transdermal drug transport. Pharm. Res., 19:1160–1169, 2002.
H.R. Guzman, D.X. Nguyen, S. Khan, and M.R. Prausnitz. Ultrasound-mediated disruption of cell membranes. I. Quantification of molecular uptake and viability. J. Acoust. Soc. Am., 110:588–596, 2001.
M.B. Sundaram J. and Mitragotri S. An experimental analysis of ultrasound-induced permeabilization. Biophy. J., 2002.
D. Miller and J. Quddus. Sonoporation of monolayer cells by diagnostic ultrasound activation of contrastagent gas bodies. Ultrasound Med. Biol., 26:661–667, 2000.
J. Wu, J.P. Ross and J.-F. Chiu. Reparable sonoporation generated by microstreaming. J. Acoust. Soc. Amer., 111:1460–1464, 2002.
J.L. Nelson, B.L. Roeder, J.C. Carmen, F. Roloff, and W.G. Pitt. Ultrasonically activated chemotherapeutic drug delivery in a rat model. Cancer Res., 62:7280–7283, 2002.
R.J. Price and S. Kaul. Contrast ultrasound targeted drug and gene delivery: an update on a new therapeutic modality. J. Cardiovasc. Pharmacol. Ther., 7:171–180, 2002.
C.S. Kwok, P.D. Mourad, L.A. Crum, and B.D. Ratner. Self-assembled molecular structures as ultrasonically-responsive barrier membranes for pulastile delivery. J. Biomed. Mater. Res., 57:151–164, 2001.
J. Kost, K. Leong, and R. Langer. Ultrasound-enhanced polymer degradation and release of incorporated substances. Proc. Natl. Acad. Sci., 86:7663–7666, 1989.
J.R. Linder. Evolving applications of contrast ultrasound. Am. J. Cardiol., 90:72J–80J, 2002.
E.C. Unger, E. Hersh, M. Vannan, T.O. Matsunaga, and T. McCreery. Local drug and genen delivery through microbubbles. Prog. Cardiovasc., 44:45–54, 2001.
H.A.E. Benson, J.C. McElnay, and R. Harland. Phonophoresis of lingocaine and prilocaine from Emla cream. Int. J. Pharm., 44:65–69, 1988.
H.A.E. Benson, J.C. McElnay, and R. Harland. Use of ultrasound to enhance percutaneous absorption of benzydamine. Phys. Ther., 69:113–118, 1989.
H.A.E. Benson, J.C. McElnay, and J. Hadgraft. Influence of ultrasound on the percutaneous absorption of nicotinate esters. Pharm. Res., 9:1279–1283, 1991.
D. Bommannan, G.K. Menon, H. Okuyama, P.M. Elias, and R.H. Guy. Sonophoresis. II. examination of the mechanism(s) of ultrasound-enhanced transdermal drug delivery. Pharm. Res., 9:1043–1047, 1992.
D. Bommannan, H. Okuyama, P. Stauffer, and R.H. Guy. Sonophoresis. I. The use of high-frequency ultrasounnd to enhance transdermal drug delivery. Pharm. Res., 9:559–564, 1992.
N.N. Byl, A. McKenzie, B. Halliday, T. Wong, and J. O’nConell. The effects of phonophoresis with corticosteroids: a controlled pilot study. J. Orth. Sports Phys. Ther., 18:590–600, 1993.
B.M. Cameroy. Ultrasound enhanced local anesthesia. Am. J. Orthoped., 8:47, 1966.
C.D. Ciccone, B.Q. Leggin, and J.J. Callamaro. Effects of ultrasound and trolamine salicylate phonophoresis on delayed-onset muscle soreness. Phys. Ther., 71:666–678, 1991.
J.E. Griffin and J. Touchstone. Ultrasonic movement of cortisol in to pig tissue. Am. J. Phys. Med., 44:20–25.
J.E. Griffin, J.L. Echternach, R.E. Proce, and J.C. Touchstone. Patients treated with ultrasonic driven hydrocortisone and with ultrasound alone. Phys. Ther., 47:600–601, 1967.
J.E. Griffin and J.C. Touchstone. Low-intensity phonophoresis of cortisol in swine. Phys. Ther., 48:1136–1344, 1968.
J. Griffin, E. and J.C. Touchstone. Effects of ultrasonic frequency on phonophoresis of cortisol into swine tissues. Am. J. Phys. Med., 51:62–78, 1972.
M.E. Johnson, S. Mitragotri, A. Patel, D. Blankschtein, and R. Langer. Synergistic effect of ultrasound and chemical enhancers on transdermal drug delivery. J. Pharm. Sci., 85:670–679, 1996.
J.A. Kleinkort and F. Wood. Phonophoresis with 1 percent versus 10 percent hydrocortisone. Phys. Ther., 55:1320–1324, 1975.
J. Kost and R. Langer, Ultrasound-mediated transdermal drug delivery. In V.P. Shah and H.I. Maibach (eds.) Topical Drug Bioavailability, Bioequivalence, and Penetration. Plennum: New York. pp. 91–103, 1993
J. Kost, U. Pliquett, S. Mitragotri, A. Yamamoto, J. Weaver, and R. Langer, Enhanced transdermal delivery: synergistic effect of ultrasound and electroporation. Pharm. Res., 13:633–638, 1996.
J. Kost, S. Mitragotri, and R. Langer. Phonophoresis. In R. Bronaugh and H.I. Maibach (eds.) Percutaneous Absorption,. pp. 615–631, 1999.
J. Kost, S. Mitragotri, R. Gabbay, M. Pishko, and L. R. Transdermal extraction of glucose and other analytes using ultrasound. Nat. Med., 6:347–350, 2000.
L. Le, J. Kost, and S. Mitragotri. Combined effect of low-frequency ultrasound and iontophoresis: applications for transdermal heparin delivery. Pharm. Res., 17:1151–1154, 2000.
M. Machluf and J. Kost. Ultrasonically enhanced transdermal drug delivery. Experimental approaches to elucidate the mechanism. J. Biomat. Sci., 5:147–156, 1993.
G. Menon, D. Bommanon, and P. Elias. High-frequency sonophoresis: permeation pathways and structural basis for enhanced permeability. Skin Pharmacol., 7:130–139, 1994.
S. Mitragotri, D. Edwards, D. Blankschtein, and R. Langer. A mechanistic study of ultrasonically enhanced transdermal drug delivery. J. Pharm. Sci., 84:697–706, 1995.
S. Mitragotri, D. Blankschtein, and R. Langer. Sonophoresis: ultrasound mediated transdermal drug delivery. In J. Swarbrick, Boylan, J. (eds.) Encl. of Pharm. Tech., Marcel Dekker, 1995.
S. Mitragotri, D. Blankschtein, and R. Langer.Transdermal drug delivery using low-frequency sonophoresis. Pharm. Res., 13:411–420, 1996.
S. Mitragotri, D. Blankschtein, and R. Langer. Sonophoresis: enhanced transdermal drug delivery by application of ultrasound. In S. J. and J. Boylan, (eds.), Encyl. Pharm. Tech.,. pp. 103–122, 1996.
S. Mitragotri, D. Blankschtein, and R. Langer. An explanation for the variation of the sonophoretic transdermal transport enhancement from drug to drug. J. Pharm. Sci., 86:1190–1192, 1997.
S. Mitragotri, J. Farrell, T. H., T. Terahara, J. Kost, and R. Langer. Determination of the threshold energy dose for ultrasound-induced transdermal drug delivery. J. Control. Rel., 63:41–52, 2000.
S. Mitragotri, D. Ray, J. Farrell, H. Tang, B. Yu, J. Kost, D. Blankschtein, and R. Langer. Synergistic effect of ultrasound and sodium lauryl sulfate on transdermal drug delivery. J. Pharm. Sci., 89:892–900, 2000.
S. Mitragotri and J. Kost. Transdermal delivery of heparin and low-molecular weight heparin using lowfrequency ultrasound. Pharm. Res., 18:1151–1156, 2000.
S. Mitragotri and J. Kost. Low-frequency sonophoresis: a non-invasive method for drug delivery and diagnostics. Biotech. Progress, 16:488–492, 2000.
S. Mitragotri. Synergistic effect of enhancers for transdermal drug delivery. Pharm. Res., 17:1354–1359, 2000.
W.S. Quillen. Phonophoresis: a review of the literature and technique. Athelet. Train., 15:109–110, 1980.
A. Tezel, A. Sanders, J. Tuchscherer, and S. Mitragotri. Synergistic effect of low-frequency ultrasound and surfactant on skin permeability. J. Pharm. Sci., 91:91–100, 2001.
T. Terahara, S. Mitragotri, and R. Langer. Porous resins as a cavitation enhancer for low-frequency sonophoresis. J. Pharm. Sci., 91:753–759, 2002.
T. Terahara, S. Mitragotri, J. Kost, and R. Langer. Dependence of low-frequency sonophoresis on ultrasound parameters; distance of the horn and intensity. Int. J. Pharm., 235:35–42, 2002.
H. Tang, D. Blankschtein, and R. Langer. Effects of low-frequency ultrasound on the transdermal penetration of mannitol: comparative studies with in vivo and in vitro studies. J. Pharm. Sci., 91:1776–1794, 2002.
H. Tang, S. Mitragotri, D. Blankschtein, and R. Langer. Theoretical description of transdermal transport of hydrophilic permeants: application to low-frequency sonophoresis. J. Pharm. Sci., 90:543–566, 2001.
A. Tezel, A. Sens, and S. Mitragotri. Investigations of the role of cavitation in low-frequency sonophoresis using acoustic spectroscopy. J. Pharm. Sci., 91:444–453, 2002.
A. Tezel, A. Sens, and S. Mitragotri. A theoretical analysis of low-frequency sonophoresis: dependence of transdermal transport pathways on frequency and energy density. Pharm. Res., 19:1841–1846, 2002.
A. Tezel, A. Sens, and S. Mitragotri.Atheoretical description of transdermal transport of hydrophilic solutes induced by low-frequency sonophoresis. J. Pharm. Sci., 92:381–393, 2003.
K. Tachibana. Transdermal delivery of insulin to alloxan-diabetc rabits by ultrasound exposure. Pharm. Res., 9:952–954, 1992.
K. Tachibana and S. Tachibana. Use of ultrasound to enhance the local anesthetic effect of topically applied aqueous lidocaine. Anestheiology, 78:1091–1096, 1993.
K. Tachibana and S. Tachibana. Transdermal delivery of insulin by ultrasonic vibration. J. Pharm. Pharmacol., 43:270–271, 1991.
A.R. Williams. Phonophoresis: an in vivo evaluation using three topical anaesthetic preparations. Ultrasonics, 28:137–141, 1990.
R. Alvarez-Roman, G. Merriono, Y.N. Kalia, A. Naik, and R. Guy. Skin permeability enhancement by low-frequency sonophoresis-lipid extraction and transport pathways. J. Pharm. Sci., 92:1138–1146, 2003.
G. Merrino, Y.N. Kalia, and R.H. Guy. Ultrasound-enhanced transdermal transport. J. Pharm. Sci., 92:1125–1137, 2003.
G. Merriono, Y.N. Kalia, M.B. Delgado-Charro, R. Potts, and R.H. Guy. Frequency and thermal effects on the enhancement of transdermal transport by sonophoresis. J. Control. Rel., 88:85–94, 2003.
L.J. Weimann and J. Wu. Transdermal delivery of poly-l-lysine by sonomacroporation. Ultrasound Med. Biol., 28:1173–1180, 2002.
A. Joshi and J. Raje. Sonicated transdermal drug transport. J. Control. Rel., 83:13–22, 2002.
L. Machet and A. Boucaud. Phonophoresis: efficiency, mechanisms, and skin tolerance. Int. J. Pharm., 243:1–15, 2002.
A. Boucaud, M.A. Garrigue, L. Machet, L. Vaillant, and F. Patat. Effect of sonication parameters on transdemral delivery of insulin to hairless rats. J. Pharm. Sci., 91:113–119, 2002.
K. Fellinger and J. Schmidt. Klinik and Therapies des Chromischen Gelenkreumatismus. Maudrich Vienna, Austria, pp. 549–552, 1954.
G.L. Coodley. Bursitis and post-traumatic lesions. Am. Pract., 11:181–187, 1960.
J.E. Griffin. Physiological effects of ultrasonica energy as it is used clinically. J. Am. Phys. Ther. Assoc., 46:18–26, 1966.
J.C. McElnay, M.P. Matthews, R. Harland, and D.F. McCafferty. The effect of ultrasound on the percutaneous absorption of lingocaine. Br. J. Clin. Pharmacol., 20:421–424, 1985.
M.A. Moll. New approaches to pain. US Armed Forces Med. Serv. DIg., 30:8–11, 1979.
D. Hofman and F. Moll. The effect of ultrasound on in vitro liberation and in vivo penetration of benzyl nicotinate. J. Control. Rel., 27:187–192, 1993.
D. Levy, J. Kost, Y. Meshulam, and R. Langer. Effect of ultrasound on transdermal drug delivery to rats and guinea pigs. J. Clin. Invest., 83:2974–2078, 1989.
S. Mitragotri and J. Kost. Low-frequency sonophoresis: a review. Adv. Drug Deliv. Rev., 56:589–601, 2004.
C.M. Gockel, S. Bao, and K.W. Beagley. Transcutaneous immunization induces mucosal and systemic immunity:a potent method for targeting immunity to the female reproductive tract. Mol. Immunol., 37:37–544, 2000.
P.L. Ogra, J. Mestecky, M.E. Lamm, W. Strober, J.R. McGhee, and J. Bienenstock. Handbook of Mucosal Immunology. New York: Acedemic Press, 1994.
T. Scharton-Kersten, J.Yu, R. Vassell, D. O’Hagan, C.R. Alving, and G.M. Glenn. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants. Infect. Immun., 68:5306–5313, 2000.
I. Roitt, J. Brostoff, and D. Male. Immunology,(5th Ed.). London: Mosby, 1998.
Tana, S.Watarai, E. Isogai, and K. Oguma. Induction of intestinal IgA and IgG antibodies preventing adhesion of verotoxin-producing Escherichia coli to Caco-2 cells by oral immunization with liposomes. Lett. Appl. Microbiol., 36:135–139, 2003.
S. Mitragotri, M. Coleman, J. Kost, and R. Langer. Transdermal extraction of analyets using low-frequency ultrasound. Pharm. Res., 17:466–470, 2000.
S. Mitragotri, M. Coleman, J. Kost, and R. Langer. Analysis of ultrasonically extracted interstitial fluid as a predictor of blood glucose values. J. Appl. Physiol., 89:961–966, 2000.
J. Kost, S. Mitragotri, T. Elstrom, N. Warner, and S. Kellogg. Ultrasonic Skin Permeabilizing Device for Transdermal Glucose Monitoring. 2nd La Jolla Conference on Diabetes, San Diego, 2003.
A.J. Singer, C.S. Homan, A.L. Church, and S.A. McClain. Low-frequency sonophoresis: pathologic and thermal effects in dogs. Acad. Emerg. Med., 5:35–40, 1998.
A. Boucaud, J. Montharu, L. Machet, B. Arbeille, M.C. Machet, F. Patat, and L. Vaillant. Clinical, histologic, and electron microscopy study of skin exposed to low-frequency ultrasound. Anatom. Rec., 264:114–119, 2001
N.P. Katz, D.E. Shapiro, T.E. Hermann, J. Kost, and L. Custer. Rapid onset of cutaneous anesthesia with EMLA cream after pretreatment with a new ultrasound emitting device. Anesth. Analg., 98:371–376, 2004.
Simmonin, On the mechanisms of in vitro and in vivo phonophoresis. J. Control. Rel., 33:125–141, 1995.
A. Tezel and S. Mitragotri. Interactions of inertial cavitation collapses with stratum corneum lipid bilayers. Biophys. J. (in press), 2003.
K.S. Suslick. Ultrasound:Its Chemical, Physical and Biological Effects. VCH Publishers, 1989.
A. Tezel and S. Mitragotri. Interactions of inertial cavitation bubbles with stratum corneum lipid bilayers during low-frequency sonophoresis. Biophys. J., 85:3502–3512, 2003.
J. Blake and D. Gibson. Cavitation bubbles near boundaries. In J. Lumley, M. Van Dyke and H. Reed (eds.), Annual Reviews of Fluid Mechanics, pp. 99–123, 1985.
Naude and A. Ellis. On the mechanisms of cavitation damage by non-hemispherical cavities in contact with solid boundary. Trans. ASME J. Basic Eng., 83:648–556, 1961.
T. Benjamin and A. Ellis. The collapse of cavitation bubbles and the pressures thereby produced against solid boundaries. Philos. Trans. R. Soc. London Ser A, 260:221–240, 1966.
W. Lauterborn and H. Bolle. Experimental investigations of cavitation bubble collapse in the neighbourhood of a solid boundary. J. Fluid. Mech., 72:391–399, 1975.
M. Plesset and R. Chapman. Collapse of an initially spherical vapour cavity in the neighbourhood of a solid boundary. J. Fluid. Mech., 47:283–290, 1971.
S. Mitragotri. Effect of bilayer disruption on transdermal transport of low-molecularweight hydrophobic solutes. Pharm. Res., 18:1022–1028, 2001.
G. Black. Interaction between anionic surfactants and skin. In K. Walters and J. Hadgraft, (eds.), Pharmaceutical Skin Penetration Enhancement, Marcel Dekker, New York, Basel, Hong Kong, pp. 145–174, 1993.
K.A. Walters, Surfactants and percutaneous absorption. In R.C. Scott, R.H. Guy, and J. Hadgraft (eds.), Predictions of Percutaneous Penetration, IBC Technical Services: London. pp. 148–162, 1990.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science + Business Media, LLC
About this chapter
Cite this chapter
Mitragotri, S. (2006). Transdermal Drug Delivery using Low-Frequency Sonophoresis. In: Ferrari, M., Desai, T., Bhatia, S. (eds) BioMEMS and Biomedical Nanotechnology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-25844-7_13
Download citation
DOI: https://doi.org/10.1007/978-0-387-25844-7_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-25565-1
Online ISBN: 978-0-387-25844-7
eBook Packages: EngineeringEngineering (R0)